Failure to Thrive
|
0.300 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Homozygous Loss-of-Function Mutations in AP1B1, Encoding Beta-1 Subunit of Adaptor-Related Protein Complex 1, Cause MEDNIK-like Syndrome.
|
31630791 |
2019 |
Skin Abnormalities
|
0.300 |
Biomarker
|
group |
GENOMICS_ENGLAND |
Homozygous Loss-of-Function Mutations in AP1B1, Encoding Beta-1 Subunit of Adaptor-Related Protein Complex 1, Cause MEDNIK-like Syndrome.
|
31630791 |
2019 |
Global developmental delay
|
0.300 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Homozygous Loss-of-Function Mutations in AP1B1, Encoding Beta-1 Subunit of Adaptor-Related Protein Complex 1, Cause MEDNIK-like Syndrome.
|
31630791 |
2019 |
Intellectual Disability
|
0.300 |
Biomarker
|
group |
GENOMICS_ENGLAND |
Homozygous Loss-of-Function Mutations in AP1B1, Encoding Beta-1 Subunit of Adaptor-Related Protein Complex 1, Cause MEDNIK-like Syndrome.
|
31630791 |
2019 |
Abnormality of copper homeostasis
|
0.300 |
Biomarker
|
phenotype |
GENOMICS_ENGLAND |
Homozygous Loss-of-Function Mutations in AP1B1, Encoding Beta-1 Subunit of Adaptor-Related Protein Complex 1, Cause MEDNIK-like Syndrome.
|
31630791 |
2019 |
Hearing abnormality
|
0.300 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Homozygous Loss-of-Function Mutations in AP1B1, Encoding Beta-1 Subunit of Adaptor-Related Protein Complex 1, Cause MEDNIK-like Syndrome.
|
31630791 |
2019 |
Ciliary Motility Disorders
|
0.200 |
Biomarker
|
group |
MGD |
|
|
|
Kartagener Syndrome
|
0.200 |
Biomarker
|
disease |
MGD |
|
|
|
HETEROTAXY, VISCERAL, 2, AUTOSOMAL
|
0.200 |
Biomarker
|
disease |
MGD |
|
|
|
HETEROTAXY, VISCERAL, 1, X-LINKED
|
0.200 |
Biomarker
|
disease |
MGD |
|
|
|
Heterotaxy, Visceral, 3, Autosomal
|
0.200 |
Biomarker
|
disease |
MGD |
|
|
|
HETEROTAXY, VISCERAL, 4, AUTOSOMAL
|
0.200 |
Biomarker
|
disease |
MGD |
|
|
|
CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 1, X-LINKED
|
0.200 |
Biomarker
|
disease |
MGD |
|
|
|
Heterotaxy Syndrome
|
0.200 |
Biomarker
|
disease |
MGD |
|
|
|
HETEROTAXY, VISCERAL, 6, AUTOSOMAL
|
0.200 |
Biomarker
|
disease |
MGD |
|
|
|
Reticulocyte count (procedure)
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
The Allelic Landscape of Human Blood Cell Trait Variation and Links to Common Complex Disease.
|
27863252 |
2016 |
Meningioma
|
0.030 |
Biomarker
|
disease |
BEFREE |
Other chromosome 22q genes implicated include BAM22, BCR (breakpoint cluster region), and TIMP-1, the last of which is implicated in higher-grade meningiomas.
|
20809251 |
2010 |
Meningioma
|
0.030 |
Biomarker
|
disease |
BEFREE |
We previously cloned the human beta'-adaptin gene (BAM22) (GDB symbol, ADTB1) from chromosome 22q12 and proposed its involvement in the development of meningiomas.
|
8812422 |
1996 |
Meningioma
|
0.030 |
GeneticVariation
|
disease |
BEFREE |
Based on this, we propose BAM22 as a second chromosome 22 locus important in meningioma development, after the neurofibromatosis type 2 gene.
|
7987321 |
1994 |
Neoplasms
|
0.020 |
Biomarker
|
group |
BEFREE |
This discrepancy supports the theory that a second tumor suppressor gene exists on chromosome 22, and the authors introduce several possible gene candidates, including BAM22, LARGE, INI1, and MN1 genes.
|
16398473 |
2005 |
Neoplasms
|
0.020 |
Biomarker
|
group |
BEFREE |
The BAM22 gene is totally inactivated in the tumor with homozygous deletion.
|
7987321 |
1994 |
Ichthyoses
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Recessive Mutations in AP1B1 Cause Ichthyosis, Deafness, and Photophobia.
|
31630788 |
2019 |
Congenital ichthyosis
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Recessive Mutations in AP1B1 Cause Ichthyosis, Deafness, and Photophobia.
|
31630788 |
2019 |
Agnosia for Pain
|
0.010 |
Biomarker
|
disease |
BEFREE |
BAM22, a bivalent agonist of MrgC and opioid receptors, enhanced the interaction between MrgC11 and MOR and produced stronger analgesia than did the individual monovalent agonists.
|
29921657 |
2018 |
Adult Meningioma
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Based on this, we propose BAM22 as a second chromosome 22 locus important in meningioma development, after the neurofibromatosis type 2 gene.
|
7987321 |
1994 |